Abstract:Pain is a multidimensional experience with sensory-discriminative, affective-motivational and cognitive-evaluative components. Although numerous neurobiological mechanisms underlying the sensory and affective dimensions of pain have been resolved, our understanding of the cognitive modulation of pain remains limited. Here, we identify circuit, cellular and synaptic mechanisms that mediate placebo analgesia, the biomedical phenomenon in which a positive expectation suffices to reduce pain. We developed a 7-day placebo analgesia conditioning (PAC) assay that generates a pain relief expectation in mice and permits evaluation of placebo analgesia. Activity-dependent genetic tagging during PAC revealed that rostral anterior cingulate cortex neurons projecting to the pontine nuclei (rACC→Pn neurons) contribute to placebo analgesia. Calcium imaging in freely moving mice trained to expect pain relief revealed a correlated increase in the activity and synchrony of rACC→Pn neurons during pain relief expectations. Whole-cell patch-clamp recording indicated that PAC increases the burst firing, AMPA/NMDA ratio and synaptic plasticity of rACC→Pn neurons, while impairing the efficiency and timing of their feedforward inhibition. Photoinhibition of the rACC-Pn pathway reversed PAC-induced analgesia. Single-cell transcriptomics suggested that 54% of Pn neurons express Oprd1 (encoding the delta opioid receptor). Additionally, photoinhibition of Oprd1+ Pn neurons abolished PAC-induced analgesia. These findings advance our current understanding of placebo analgesia and cognitive modulation of pain, from the merely brain-area level to the circuit, cellular and synaptic levels, bridge the gap with our more advanced understanding of the sensory and affective dimensions of pain, and open the possibility of using this pathway to promote positive outcomes during pain management. National Institutes of Health grant R01NS106301 (G.S.), New York Stem Cell Foundation (G.S.), Stanford School of Medicine Dean's Fellowship (C.C.).

A new animal model of placebo analgesia: involvement of the dopaminergic system in reward learning

Failure of Placebo Analgesia Model in Rats with Inflammatory Pain.

Reverse engineering placebo analgesia

A novel investigation of placebo analgesia through social communication in mice

Impaired Feedforward Inhibition Of Corticopontine Neurons Drives Placebo Analgesia

Dynamic Changes of Tyrosine Hydroxylase and Dopamine Concentrations in the Ventral Tegmental Area-Nucleus Accumbens Projection During the Expression of Morphine-Induced Conditioned Place Preference in Rats

Neural circuit basis of placebo pain relief

Persistent Pain Facilitates Response to Morphine Reward by Downregulation of Central Amygdala GABAergic Function

Brain and body: Implanting a placebo in the brain to alleviate pain

Reactivation of Morphine Conditioned Place Preference by Drug Priming: Role of Environmental Cues and Sensitization

Upregulation of Tumor Necrosis Factor-Alpha in Nucleus Accumbens Attenuates Morphine-Induced Rewarding in a Neuropathic Pain Model.

The Activation of NMDA Receptor–ERK Pathway in the Central Amygdala is Required for the Expression of Morphine-Conditioned Place Preference in the Rat

Endogenous histamine inhibits the development of morphine-induced conditioned place preference

The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.

Accumbal dopamine and serotonin activity throughout acquisition and expression of place conditioning: correlative relationships with preference and aversion

[Changs of Kappa Opioid Receptor Expression in Central Amygdaloid Nuclei During the Process of Chronic Morphine-Induced Conditioned Place Aversion in Rats].

Disruption of positive- and negative-feature morphine interoceptive occasion setters by dopamine receptor agonism and antagonism in male and female rats

The role of CA3-LS-VTA loop in the formation of conditioned place preference induced by context-associated reward memory for morphine.

Coordinated Activity of a Central Pathway Drives Associative Opioid Analgesic Tolerance

BDNF-AAV has protective effects on morphine-induced conditioned place preference through BDNF, TrkB, and CREB concentration changes in the VTA and NAc

A Context-Based Analgesia Model in Rats: Involvement of Prefrontal Cortex